Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-03-23

Clinical Trial Update: Overnight Feeding Study in Glycogen Storage Disease Type 1 [NA]

View source ↗

Summary

The University of Zurich-conducted overnight feeding study in patients with glycogen storage disease type I has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Zurich | Conditions: Glycogen Storage Disease Type 1 (GSD 1) | NA | Status: COMPLETED